Success Metrics

Clinical Success Rate
70.4%

Based on 38 completed trials

Completion Rate
70%(38/54)
Active Trials
9(11%)
Results Posted
108%(41 trials)
Terminated
16(20%)

Phase Distribution

Ph not_applicable
10
12%
Ph early_phase_1
3
4%
Ph phase_1
8
10%
Ph phase_2
6
7%
Ph phase_3
9
11%
Ph phase_4
45
56%

Phase Distribution

11

Early Stage

6

Mid Stage

54

Late Stage

Phase Distribution81 total trials
Early Phase 1First-in-human
3(3.7%)
Phase 1Safety & dosage
8(9.9%)
Phase 2Efficacy & side effects
6(7.4%)
Phase 3Large-scale testing
9(11.1%)
Phase 4Post-market surveillance
45(55.6%)
N/ANon-phased studies
10(12.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

61.3%

38 of 62 finished

Non-Completion Rate

38.7%

24 ended early

Currently Active

9

trials recruiting

Total Trials

81

all time

Status Distribution
Active(13)
Completed(38)
Terminated(24)
Other(6)

Detailed Status

Completed38
Terminated16
Recruiting9
Withdrawn8
unknown6
Enrolling by invitation3

Development Timeline

Analytics

Development Status

Total Trials
81
Active
9
Success Rate
70.4%
Most Advanced
Phase 4

Trials by Phase

Early Phase 13 (3.7%)
Phase 18 (9.9%)
Phase 26 (7.4%)
Phase 39 (11.1%)
Phase 445 (55.6%)
N/A10 (12.3%)

Trials by Status

recruiting911%
completed3847%
not_yet_recruiting11%
terminated1620%
enrolling_by_invitation34%
unknown67%
withdrawn810%

Recent Activity

9 active trials
Showing 5 of 81
completedphase_4

Exparel Use in Peripheral Nerve Blocks and Local Infiltration for Foot and Ankle Surgery

NCT05494645
recruitingphase_2

Evaluation of Pain Management After Surgery When Using Exparel in the Pediatric Population

NCT06559215
recruitingphase_3

Efficacy of EXPAREL vs. Bupivacaine

NCT07212114
recruitingphase_3

R.E.C.K vs Exparel in Robotic Nephrectomy

NCT07092566
recruitingphase_1

Study to Evaluate the Pharmacokinetics and Safety of EXPAREL for Postoperative Analgesia in Subjects Undergoing Cardiac Surgery

NCT06271265
View all 81 trials

Clinical Trials (81)

Showing 20 of 81 trialsScroll for more
NCT05494645Phase 4

Exparel Use in Peripheral Nerve Blocks and Local Infiltration for Foot and Ankle Surgery

Completed
NCT06559215Phase 2

Evaluation of Pain Management After Surgery When Using Exparel in the Pediatric Population

Recruiting
NCT07212114Phase 3

Efficacy of EXPAREL vs. Bupivacaine

Recruiting
NCT07092566Phase 3

R.E.C.K vs Exparel in Robotic Nephrectomy

Recruiting
NCT06271265Phase 1

Study to Evaluate the Pharmacokinetics and Safety of EXPAREL for Postoperative Analgesia in Subjects Undergoing Cardiac Surgery

Recruiting
NCT04575688Phase 4

Periarticular Injection Versus Popliteal Block

Enrolling By Invitation
NCT06574022Phase 4

Post-mastectomy Recovery: Comparing Preoperative PECS-II Blocks With Intraoperative Pectoral Blocks

Recruiting
NCT03827291Phase 4

QL Block With Exparel in Colectomy

Completed
NCT05171179Phase 3

The Use of Pecs Blocks in Combination With Exparel in Breast Reconstruction Surgery

Completed
NCT05285566Phase 4

Pain Control for Undergoing Costal Cartilage Harvesting

Recruiting
NCT02128646Phase 4

Liposomal Bupivacaine (Exparel) for Postoperative Pain Control for Open and Laparoscopic Abdominal Hernia Repair

Completed
NCT03737292Phase 4

Liposomal Bupivacaine Versus Plain Bupivacaine After Intercostal Injections For Pain Management After Thoracoscopy

Recruiting
NCT06349772Early Phase 1

Zynrelef vs Exparel: The Battle of Postoperative Pain Control After Robotic Sleeve Gastrectomy

Recruiting
NCT06350981Phase 2

Analgesic Requirement for Post-Operative Pain Control in TLIP Interbody Fusion

Enrolling By Invitation
NCT04364867Phase 4

Exparel for Total Shoulder Arthroplasty

Completed
NCT06619340Phase 4

EXPAREL IPSA Block in Knee Arthroplasty

Enrolling By Invitation
NCT03738696Phase 4

Liposomal Bupivacaine in Rotator Cuff Repair

Completed
NCT02805504Phase 4

Liposomal Bupivacaine for Postoperative Pain Control in Urologic Procedures

Completed
NCT06274008Phase 1

Exparel vs. ACB With Bupivacaine for ACL Reconstruction

Recruiting
NCT02996227Not Applicable

Bilateral Transversus Abdominis Plane Block With Exparel Verus Continuous Epidural Analgesia With Bupivacaine

Completed

Drug Details

Intervention Type
DRUG
Total Trials
81